The venture studio located in New York City. In addition to its core venture creation function, the group in early-stage digital health companies looking to enter the US market for which its platform can offer catalytic growth. In addition to providing capital, the firm assists companies with regulatory approval and commercialization in the US, through their unique company creation partnership with a large health system.
The firm invests across the spectrum of digital health, with a particular focus on companies developing AI-based technologies, virtual care and other health-related technologies.
The firm generally seeks to work hand-in-hand with management to drive value creation and assist portfolio companies with US market entry. They work with pre-revenue companies, as well as with those that are more advanced internationally and looking to enter the US market. The firm considers both minority investments and acquisitions.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Next Phase Newsletter 
Leave a Reply